Showing results (151-160 of 397) with videos related to

Sort By:
Pageof 40
Mutation Research|August 9, 2005
Molecular mechanisms of action of angiopreventive anti-oxidants on endothelial cells: microarray gene expression analysesUlrich Pfeffer, Nicoletta Ferrari, Raffaella Dell'Eva, et al.
Frontiers in Oncology|July 30, 2014
Orchestration of angiogenesis by immune cellsAntonino Bruno, Arianna Pagani, Laura Pulze, et al.
Gastroenterology Research|June 20, 2018
Denture-Associated Oral Microbiome and Periodontal Disease Causing an Anaerobic Pyogenic Liver Abscess in an Immunocompetent Patient: A Case report and Review of the LiteratureMuhammad Bader Hammami, Elizabeth M Noonan, Anuj Chhaparia, et al.
Frontiers in Immunology|June 26, 2023
The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditionsValentina Carlini, Douglas M Noonan, Eslam Abdalalem, et al.
Frontiers in Oncology|June 17, 2022
Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung CancerMaria Gemelli, Douglas M Noonan, Valentina Carlini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 1998
Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNAR Adatia, A Albini, S Carlone, et al.
Biochemical and Biophysical Research Communications|June 30, 2000
Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathologyM Morini, R Benelli, D Giunciuglio, et al.
Clinical & Experimental Metastasis|June 18, 2002
Role of the alpha3beta1 and alpha6beta4 integrins in tumor invasionGianluigi Giannelli, Simonetta Astigiano, Salvatore Antonaci, et al.
Frontiers in Immunology|October 14, 2021
Preliminary Evidence for IL-10-Induced ACE2 mRNA Expression in Lung-Derived and Endothelial Cells: Implications for SARS-Cov-2 ARDS PathogenesisAdriana Albini, Luana Calabrone, Valentina Carlini, et al.
Cancer Letters|April 22, 2018
Acetyl-l-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathwaysDenisa Baci, Antonino Bruno, Barbara Bassani, et al.
Pageof 40